{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-105037","form_type":"8-K","ticker":"DH","cik":"0001861795","company_name":"Definitive Healthcare Corp.","filed_at":"2025-08-07T23:59:59+00:00","discovered_at":"2026-05-14T18:02:45.425006+00:00","generated_at":"2026-05-17T18:21:38.840830+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Definitive Healthcare Q2 revenue $60.8M (-5% YoY); raises FY revenue guidance bottom by $3M","bullets":["Q2 net loss $(9.3)M vs $(306.2)M (prior year included $363.6M goodwill impairment).","Adjusted net income $9.7M, down from $14.2M in Q2 2024; adjusted EBITDA $18.7M (31% margin).","Q3 2025 revenue guidance $59-60M; FY 2025 raised to $237-240M from $234-240M.","Adjusted net income per diluted share for Q3 guided at $0.05-0.06; FY at $0.22-0.23.","Customer wins include a revenue cycle management firm and a digital health org returning after non-renewal."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-105037","json":"https://secwatch.observer/filing/0000950170-25-105037.json","markdown":"https://secwatch.observer/filing/0000950170-25-105037.md","text":"https://secwatch.observer/filing/0000950170-25-105037.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1861795/000095017025105037/0000950170-25-105037-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1861795/000095017025105037/dh-20250807.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T18:21:38.840830+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}